Ttuhsc Dept Of Dermatology

CLIA Laboratory Citation Details

3
Total Citations
14
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 45D0695067
Address 3601 4th Street Suite 4a100, Lubbock, TX, 79430
City Lubbock
State TX
Zip Code79430
Phone(806) 743-1842

Citation History (3 surveys)

Survey - September 9, 2025

Survey Type: Standard

Survey Event ID: X8MY11

Deficiency Tags: D5417 D5417

Summary:

Summary Statement of Deficiencies D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) (d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based upon observations, review of reagent logs, review of the CMS 116 Application and interview of facility personnel, the laboratory failed to ensure expired Gill 2 Hematoxylin stain was not used beyond expiration when staining 496 patient specimens. The findings included: 1. Observations made in the histology department on September 9, 2025 at 2:21 PM found one partially filled container of Gill 2 Hematoxylin lot 169443 expiration 2024-09-30 in the flammable cabinet. The stain was received . 2. Review of the reagent logs found the laboratory documented receipt of the stain on December 13, 2023 with no in use date recorded. 3. Review of the CMS 116 application found the laboratory reported an annual volume of 496 specimens using the Hematoxylin and Eosin (H and E) staining procedure. 4. During interview of the nurse manager conducted September 9, 2025 at 2:37 PM, she confirmed the Hematoxylin stain was expired. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - November 2, 2023

Survey Type: Standard

Survey Event ID: 0DD911

Deficiency Tags: D0000 D5413 D3031 D5413

Summary:

Summary Statement of Deficiencies D0000 The laboratory was surveyed and found to be in compliance with the Conditions of the CLIA regulations found at 42 CFR 493.1 through 493.1780, and recertification is recommended. D3031 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(3) Analytic systems records. Retain quality control and patient test records (including instrument printouts, if applicable) and records documenting all analytic systems activities specified in 493.1252 through 493.1289 for at least 2 years. This STANDARD is not met as evidenced by: I. Based on review of the laboratory's records and interview, the laboratory failed to retain the chemical name and concentration (if applicable), manufacturer, lot number, expiration date, received date, and open date of the chemicals and stains used in the laboratory in Mohs processing for two of two years reviewed. Findings follow. A. The reagent log was requested on November 2, 2023 at 1035 in the office but not provided. B. Interview with the LVN on November 2, 2023 at 1035 hours in the office confirmed the laboratory did not maintain a reagent log. II. Based on review of the Mohs test reports and interview, the laboratory failed to retain the Mohs map for four of 11 patients reviewed. Findings follow. A. Review of the Mohs test report showed 4 were missing the maps as listed by case number and date of service: 1. M22-302 06/28 /2022 2. M22-431 09/20/2022 3. M23-320 07/17/2023 4. M23-410 09/18/2023 B. Interview with the LVN on November 2, 2023 at 1215 hours in the office confirmed the Mohs maps were missing for four of the cases selected. D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on review of the manufacturer's instructions, the laboratory's policy and procedure, laboratory logs, patient testing logs, interview, and pre-survey paperwork, the laboratory failed to document the room temperature and humidity of the laboratory for nine out of 56 days of Mohs testing reviewed. Findings follow. A. Review of the Leica CM1860 Instructions for Use, 10/2016, under Technical Data stated, "Operating Temperature range (ambient temperature): 18 to 35 degrees Celsius. All specifications related to temperature of the cooling unit are valid only for an ambient temperature of 22 degrees Celsius and a relative humidity of no more than 60%." B. Review of the laboratory's policy and procedure titled Mohs Lab cryostat and ambient temperature and humidity policy, effective 09/27/2019, stated, "Room temperature for Leica Cryostat should range from 18 degrees Celsius to 35 degrees Celsius and ambient temperature of 22 degrees Celsius and maximum air humidity of 60%." C. Review of the laboratory's Dermatology Mohs Lab form from 05/01/2023 - 09/18/2023 showed missing documentation on the following nine days of Mohs testing: 1. 05/03/2023 2. 05/08/2023 3. 07/18/2023 4. 07/19/2023 5. 07/24/2023 6. 07/25/2023 7. 08/08/2023 8. 08/09/2023 9. 09/12/2023 D. Review of the patient logs showed the following patients were tested: 1. 05/03/2023 M23-205 - M23-211 2. 05/08/2023 M23-212 3. 07/18 /2023 M23-322 - M23-323 4. 07/19/2023 M23-324 - M23-329 5. 07/24/2023 M23- 330 - M23-331 6. 07/25/2023 M23-332 - M23-333 7. 08/08/2023 M23-352 - M23- 353 8. 08/09/2023 M23-354 - M23-360 9. 09/12/2023 M23-401 - M23-402 E. Interview with the LVN on November 2, 2023 at 1240 hours confirmed after a review of the records, the temperature and humidity were not recorded every day of patient testing. F. Review of the CMS Form 116 showed approximately 450 cases were performed annually. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 5, 2020

Survey Type: Standard

Survey Event ID: BKWJ11

Deficiency Tags: D5217 D5413 D5417 D5805 D5217 D5413 D5417 D5805

Summary:

Summary Statement of Deficiencies D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on review of patient testing logs, accuracy assessments, and interview, the laboratory failed to ensure accuracy assessments were performed at least twice annually for Tzanck testing for 2 of 2 years reviewed. Findings follow. Review of patient testing logs showed 17 patients were tested for Tzanck from 2018 - 2020: 2 patients in 2020, 4 patients in 2019, and 11 patients since the last survey on Feb 19, 2018. No accuracy assessments for Tzanck testing were available for review at the time of the survey. Interview with the LVN with the initials SH on 10/06/2020 at 1610 hours in the office acknowledged they perform so few Tzanck testing. Interview with the LVN with the initials SH on 10/06/2020 at 1635 hours in the office confirmed accuracy assessments were not done for Tzanck smears. Key: LVN: Licenssed Vocational Nurse D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- This STANDARD is not met as evidenced by: Based on review of manufacturer's instructions, policy and procedures, temperature charts, and interview, the laboratory failed to define the acceptable range for room temperature and humidity. Findings follow. Review of Leica CM1860/CM1860UV - Cryostat Instructions for Use Manual, rev 10/2016, on page 18 stated under Chapter 4. Setting up the Instrument, "The place of installation must meet the following requirements: ... Room temperature consistently 18 degrees C (Celsius) - 35 degrees C... Relative humidity, maximum 60%". Review of the facility's policy and procedure titled Cryo Stat Policy under "Text" stated, "5) Ambient room temperature will be maintained 18 degrees Celsius to 35 degrees Celsius with Humidity less than 60%". No room temperatures were available for review for the Mohs laboratory. Other temperatures were recorded from March 2018-September 2020 but room temperature was not recorded. Humidity was recorded, but the acceptable range was not on the form, and the laboratory exceeded 60% humidity on 2 of 30 days from May through September 2020: June 24, 2020 and Sept 2, 2020. Interview with the LVN with the initials SH on 10/06/2020 at 1650 hours in the reception area confirmed room temperature was not documented on the days for Mohs and the acceptable ranges are not defined on the form. KEY: LVN: Licensed Vocational Nurse D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on observation and interview, the laboratory failed to ensure expired reagents were not used for testing. Findings follow. 1. Surveyor observed on 10/06/2020 at 1525 hours in the laboratory the Marking Dye available and in use for Mohs testing was expired. The Orange Tissue Marking Dye, Lot 063265, had an expiration date of 1 /20, the Green Tissue Marking Dye, Lot 066442, had an expiration date of 5/20, the Red Tissue Marking Dye, Lot 066681, had an expiration date of 5/20, the Black Tissue Marking Dye, Lot 065951, had an expiration date of 4/20, the Yellow Tissue Marking Dye, Lot 064984, had an expiration date of 3/20. No other marking dyes were available for use in the laboratory. Interview with the LVN with the initials SH on 10/06/2020 at 1525 hours in the laboratory confirmed the marking dyes were expired. 2. Surveyor observed on 10/06/2020 at 1445 hours next to the microscope, the PMS Fungal/Tzanck Stain currently in use, Lot K18911, expired on 09-30-2020. Review of patient logs showed no patients were tested since its expiration. Interview with the LVN with the initials SH on 10/06/2020 at 1445 hours in the hall verified the stain was expired. 3. Surveyor observed on 10/06/2020 at 1530 hours in the laboratory 4 of 4 bottles of the Tissue Freezing Media Neg-50, Lot 410250, had an expiration of 10/2019. Interview with the histotechnician with the initials CP on 10/06/2020 at 1530 hours in the laboratory acknowledged he hasn't used it in a long time. Key: LVN: Licensed Vocational Nurse D5805 TEST REPORT CFR(s): 493.1291(c) The test report must indicate the following: (c)(1) For positive patient identification, -- 2 of 3 -- either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: Based on review of patient test reports and interview, the laboratory failed to include the facility address on the Mohs reports on 2 out of 3 reports reviewed. Review of the Mohs patient reports showed case #s 20-001 and 19-340 were missing the address of the location where the test was performed. Interview with the LVN with the initials SH on 10/06/2020 at 1715 hours in the office confirmed the test reports were missing the facility address. KEY: LVN: Licensed Vocational Nurse -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access